Depression and Anxiety Trial, Recruiting NCT07421063 Sponsor: Abant Izzet Baysal University Condition: Depression and Anxiety
Back to Depression And Anxiety

Depression and Anxiety Trial, Recruiting

NCT07421063
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Parents of newborns who are going through their baby's first newborn hearing screening test.
  • People who can communicate effectively in the local language with no language barriers.
  • People who have no previous experience or training in a technique called Emotional Freedom Technique (EFT).
  • People who agree to take part voluntarily and sign a consent form.

Who may not be able to join:

  • People with a known history of diagnosed mental health (psychiatric) conditions or epilepsy.
  • Situations where the newborn baby is crying or being breastfed right before or during the study assessment.
  • Cases where the baby's scheduled hearing screening begins before the study's 30–35 minute process has been completed.
  • Situations where sudden stressful events or environmental distractions occur that could affect the accuracy of anxiety measurements during the study.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Sümeyra Alan, PhD, Bolu Abant İzzet Baysal Üniversitesi

Phone: +90 5054568535

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Abant Izzet Baysal University
Registry
ClinicalTrials.gov
Start date
31 March 2026
Est. completion
14 July 2026

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

State Anxiety Inventory (STAI-S) Score

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov